Biden Drug Czar Says Marijuana Rescheduling Is ‘Based On Science And Evidence’ But Misstates Impact On Prescription Access

The Biden administration’s drug czar said this week that the Justice Department’s recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) is one “based on science and evidence,” adding that the change will ease research restrictions around the use of cannabis to treat “chronic illnesses, chronic pain and…... Continue Reading →